Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
NCT07165626 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-09-10
Summary
The goal of this interventional study is to assess the dynamics of structural and functional retinal changes in eyes with epiretinal membrane (ERM) after pars plana vitrectomy (PPV). Other study objectives include:
* Identification of preoperative prognostic factors associated with better postoperative outcomes.
* Evaluation of the utility of advanced, highly specialized retinal function testing as diagnostic-prognostic tools in patients after ERM surgery.
* Definition of updated qualification criteria and surgical indications for vitrectomy in patients with ERM.
Researchers will compare a laser-treated group (additional subthreshold micropulse yellow laser (577 nm) at 1 month post-PPV) with a nonlaser group (no additional laser) to see whether early postoperative subtreshold micropulse laser therapy (SMLT) affects selected functional and morphometric retinal parameters after ERM peeling.
This prospective, randomized, controlled, single-center study includes 100 pseudophakic patients scheduled for surgical ERM removal.
Eligibility requires a visually significant ERM with metamorphopsia and/or reduced best-corrected visual acuity.
Participants are classified preoperatively by OCT-based Govetto staging and randomized 1:1 to either the laser-treated group or the non-laser (control) group. All patients undergo standard 25-gauge PPV with ERM peeling, followed by ILM peeling and SF₆ gas tamponade, performed by a single experienced vitreoretinal surgeon.
Follow-up visits occur preoperatively, and at 1 and 4 months postoperatively; SMLT is performed at 1 month in the laser arm. Baseline questionnaire captures metamorphopsia presence (yes/no) and duration (\<6, 6-12, \>12 months).
Assessments include:
* best corrected visual acuity (BCVA) \[Snellen and ETDRS charts\]
* enhanced depth imaging optical coherence tomography (EDI-OCT) \[retinal thickness in the nine Early Treatment Diabetic Retinopathy Study (ETDRS) subfields (μm); total retinal volume (mm³); subfoveal choroidal thickness (μm); choroidal area (mm²)\]
* OCT angiography (OCTA) \[foveal avascular zone (FAZ) area in both the superficial (SVC) and deep vascular complexes (DVC) (mm²)\]
* multifocal electroretinography (mfERG) \[P1-wave retinal response density (nV/deg²) in rings R1-R6; P1-wave implicit (peak) time in rings R1-R6 (ms)\]
* microperimetry (average threshold (dB); fixation stability P1/P2; fixation variability via 63% and 95% bivariate contour ellipse area (BCEA)\]
* wide-field fundus imaging
Statistical analyses will be performed at a significance level of p\<0.05, using appropriate parametric or nonparametric methods selected based on data distribution and measurement scale.
Conditions
- Epiretinal Membrane
- Macular Oedema
- Macular Diseases
- Retinal Diseases
Interventions
- DEVICE
-
Subtreshold micropulse laser therapy
Laser-treated group will receive additional subthreshold micropulse laser therapy (SMLT) 1 month after pars plana vitrectomy (PPV), using a 577 nm solid-state yellow diode laser applied to the macular area (thirty 5 × 5 spot sizes of 160 µm, zero-spot spacing, including the fovea; fixed power 250 mW; exposure time 200 ms; micropulse mode, 5% duty cycle). Control group (nonlaser group) will not receive additional laser treatment.
- PROCEDURE
-
Pars plana vitrectomy
Both groups will undergo pars plana vitrectomy (PPV) with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling prior to allocation to study arms.
Sponsors & Collaborators
-
Pomeranian Medical University Szczecin
lead OTHER
Principal Investigators
-
Anna Machalińska, Prof., MD, PhD · First Department of Ophthalmology, Pomeranian Medical University in Szczecin, Poland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-09
- Primary Completion
- 2026-09-30
- Completion
- 2027-04-30
Countries
- Poland
Study Locations
More Related Trials
-
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria
NCT02871531 ·Status: UNKNOWN ·Phase: NA
-
Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
NCT01771939 ·Status: COMPLETED ·Phase: NA
-
Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment
NCT04158622 ·Status: UNKNOWN ·Phase: NA
-
Choroidal Thickness Vitrectomy
NCT02617147 ·Status: COMPLETED
-
Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery
NCT04158791 ·Status: COMPLETED
-
Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy
NCT03902795 ·Status: COMPLETED
-
Evaluation of Intraoperative Slow-release Dexamethasone Implant for Epiretinal Membrane
NCT05416827 ·Status: UNKNOWN ·Phase: NA
-
EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE
NCT07140692 ·Status: COMPLETED ·Phase: NA
-
Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD
NCT00926861 ·Status: UNKNOWN
-
20- Versus 23- Gauge System for Pars Plana Vitrectomy
NCT00411970 ·Status: COMPLETED ·Phase: PHASE4
-
Early Prevention Strategies of Severe Proliferative Vitreoretinopathy Base on Precision Diagnosis of Single Cell Sequencingvitreoretinopathy
NCT04520789 ·Status: UNKNOWN ·Phase: NA
-
Outcomes of Vitrectomy in Pediatric Retinal Detachment With Proliferative Vitreoretinopathy
NCT03208205 ·Status: COMPLETED
-
Evolution of EIFL Following PPV
NCT06040216 ·Status: COMPLETED
-
Fourier Transformed Infrared Spectroscopy in Macular Surgery
NCT03452748 ·Status: COMPLETED ·Phase: NA
-
Early Vitrectomy for Impending Macular Hole
NCT01121965 ·Status: UNKNOWN ·Phase: NA
-
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment
NCT01639209 ·Status: COMPLETED ·Phase: NA
-
Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment
NCT05069675 ·Status: UNKNOWN
-
23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments
NCT01716507 ·Status: COMPLETED ·Phase: NA
-
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
NCT04278079 ·Status: COMPLETED ·Phase: NA
-
Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy
NCT01478516 ·Status: UNKNOWN ·Phase: NA
-
Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen
NCT03927430 ·Status: COMPLETED
-
Minimal Vitrectomy Surgery for Epiretinal Membrane
NCT07019896 ·Status: RECRUITING ·Phase: NA
-
Pars Plana Vitrectomy Combined With Phacoemulsification Cataract Surgery in Phakic Diabetes Retinopathy Patients
NCT04729023 ·Status: COMPLETED ·Phase: NA
-
The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy
NCT01255306 ·Status: COMPLETED
-
Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling
NCT00556244 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2